nach oben

Erschienen in:

01.06.2012 | Review Article

Current Strategies and Future Perspectives for Intraperitoneal Adhesion Prevention

verfasst von: Christoph Brochhausen, Volker H. Schmitt, Constanze N. E. Planck, Taufiek K. Rajab, David Hollemann, Christine Tapprich, Bernhard Krämer, Christian Wallwiener, Helmut Hierlemann, Rolf Zehbe, Heinrich Planck, C. James Kirkpatrick

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The formation of peritoneal adhesions still is a relevant clinical problem after abdominal surgery. Until today, the most important clinical strategies for adhesion prevention are accurate surgical technique and the physical separation of traumatized serosal areas. Despite a variety of barriers which are available in clinical use, the optimal material has not yet been found.

Discussion

Mesothelial cells play a crucial physiological role in frictionless gliding of the serosa and the maintenance of an antiadhesive surface. The formation of postoperative adhesions results from a cascade of events and is regulated by various cellular and humoral factors. Therefore, optimization or functionalization of barrier materials by developments interacting with this cascade on a structural or pharmacological level could give an innovative input for future strategies in peritoneal adhesion prevention. For this purpose, the proper understanding of the formal pathogenesis of adhesion formation is essential. Based on the physiology of the serosa and the pathophysiology of adhesion formation, the available barriers in current clinical practice as well as new innovations are discussed in the present review.

diZerega GS, Cortese S, Rodgers KE, Block KM, Falcone SJ, Juarez TG, Berg R: A modern biomaterial for adhesion prevention. J Biomed Mater Res B Appl Biomater 2007; 81(1): 239-50PubMed

Brochhausen C, Schmitt, V.H. , Krämer, B., Rajab, T.K., Wallwiener, M., Planck, C., Hierlemann, H., Planck, H., Kirkpatrick, C.J.: Intraperitoneale Adhäsionen - Eine Herausforderung an der Schnittstelle von Materialforschung und Biomedizin. BIOmaterialien 2009; 10: 7-17CrossRef

Brochhausen C, Schmitt VH, Rajab TK, Planck CNE, Krämer B, Wallwiener M, Hierlemann H, Kirkpatrick CJ: Intraperitoneal adhesions—an ongoing challenge between biomedical engineering and the life sciences. J Biomed Mater Res A 2011; 98(1): 143-56.PubMed

Weibel MA, Majno G: Peritoneal adhesions and their relation to abdominal surgery. A postmortem study. Am J Surg 1973; 126(3): 345-53.PubMedCrossRef

Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D, McGuire A, Lower AM, Hawthorn RJ, O’Brien F, Buchan S, Crowe AM: Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 1999; 353(9163): 1476-80.PubMedCrossRef

Al-Jabri S, Tulandi T: Management and prevention of pelvic adhesions. Semin Reprod Med 2011; 29(2): 130-7.PubMedCrossRef

Almeida OD, Jr., Val-Gallas JM: Conscious pain mapping. J Am Assoc Gynecol Laparosc 1997; 4(5): 587-90PubMedCrossRef

Rajab TK, Wallwiener M, Talukdar S, Kraemer B: Adhesion-related complications are common, but rarely discussed in preoperative consent: a multicenter study. World J Surg 2009; 33(4): 748-50.PubMedCrossRef

Howard FM, El-Minawi AM, Sanchez RA: Conscious pain mapping by laparoscopy in women with chronic pelvic pain. Obstet Gynecol 2000; 96(6): 934-9.PubMedCrossRef

10.

Marana R, Muzii L: Infertility and adhesions. In: diZerega GS (ed) Peritoneal surgery. New York: Springer, 2000; 329–33CrossRef

11.

Wallwiener M, Brucker S, Hierlemann H, Brochhausen C, Solomayer E, Wallwiener C: Innovative barriers for peritoneal adhesion prevention: liquid or solid? A rat uterine horn model. Fertil Steril 2006; 86(4 Suppl): 1266-76.PubMedCrossRef

12.

Cheong YC, Laird SM, Li TC, Shelton JB, Ledger WL, Cooke ID: Peritoneal healing and adhesion formation/reformation. Hum Reprod Update 2001; 7(6): 556-66.PubMedCrossRef

13.

Boland GM, Weigel RJ: Formation and prevention of postoperative abdominal adhesions. J Surg Res 2006; 132(1): 3-12.PubMedCrossRef

14.

Lower AM, Hawthorn RJ, Ellis H, O’Brien F, Buchan S, Crowe AM: The impact of adhesions on hospital readmissions over ten years after 8849 open gynaecological operations: an assessment from the Surgical and Clinical Adhesions Research Study. Bjog 2000; 107(7): 855-62.PubMed

15.

Coleman MG, McLain AD, Moran BJ: Impact of previous surgery on time taken for incision and division of adhesions during laparotomy. Dis Colon Rectum 2000; 43(9): 1297-9.PubMedCrossRef

16.

Van Der Krabben AA, Dijkstra FR, Nieuwenhuijzen M, Reijnen MM, Schaapveld M, Van Goor H: Morbidity and mortality of inadvertent enterotomy during adhesiotomy. Br J Surg 2000; 87(4): 467-71.CrossRef

17.

Ray NF, Larsen JW, Jr., Stillman RJ, Jacobs RJ: Economic impact of hospitalizations for lower abdominal adhesiolysis in the United States in 1988. Surg Gynecol Obstet 1993; 176(3): 271-6.PubMed

18.

Ray NF, Denton WG, Thamer M, Henderson SC, Perry S: Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg 1998; 186(1): 1-9.PubMedCrossRef

19.

Bittinger F, Klein CL, Skarke C, Brochhausen C, Otto M, Köhler H, Kirkpatrick CJ: A three-dimensional cell culture method for studying peritoneal adhesions. In: Treutner K-H, Schumpelick, V (eds) Peritoneal adhesions. Heidelberg: Springer, 1997; 49-63.CrossRef

20.

Thors F, Drukker J: Serous membranes and their development, structure, and topography. In: Treutner K-H, Schumpelick V (eds) Peritoneal adhesions. Heidelberg: Springer, 1997; 3-13.CrossRef

21.

Beavis J, Harwood JL, Coles GA, Williams JD: Synthesis of phospholipids by human peritoneal mesothelial cells. Perit Dial Int 1994; 14(4): 348-55.PubMed

22.

Zhong JH, Guo QY, Ye RG, Lindholm B, Wang T: Phospholipids in dialysate and the peritoneal surface layer. Adv Perit Dial 2000; 16: 36-41.PubMed

23.

Hills BA, Burke JR, Thomas K: Surfactant barrier lining peritoneal mesothelium: lubricant and release agent. Perit Dial Int 1998; 18(2): 157-65.PubMed

24.

Merlo G, Fausone G, Barbero C, Castagna B: Fibrinolytic activity of the human peritoneum. Eur Surg Res 1980; 12(6): 433-8.PubMedCrossRef

25.

van Hinsbergh VW, Kooistra T, Scheffer MA, Hajo van Bockel J, van Muijen GN: Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990; 75(7): 1490-7.PubMed

26.

Yao V, Platell C, Hall JC: Role of peritoneal mesothelial cells in peritonitis. Br J Surg 2003; 90(10): 1187-94.PubMedCrossRef

27.

Bittinger F, Brochhausen C, Kohler H, Lehr HA, Otto M, Starke C, Walgenbach S, Kirkpatrick CJ: Differential expression of cell adhesion molecules in inflamed appendix: correlation with clinical stage. J Pathol 1998; 186(4): 422-8.PubMedCrossRef

28.

Brochhausen C: Die Expression und Kinetik von Zelladhäsionsmolekülen in der entzündeten Appendix vermiformis: Ihre pathophysiologische und diagnostische Relevanz. Frankfurt am Main: Verlag Neue Wissenschaft, 2002

29.

Glucksman DL: Serosal integrity and intestinal adhesions. Surgery 1966; 60(5): 1009-11.PubMed

30.

Hubbard TB, Jr., Khan MZ, Carag VR, Jr., Albites VE, Hricko GM: The pathology of peritoneal repair: its relation to the formation of adhesions. Ann Surg 1967; 165(6): 908-16.PubMedCrossRef

31.

Raftery AT: Regeneration of parietal and visceral peritoneum: an electron microscopical study. J Anat 1973; 115(Pt 3): 375-92.PubMed

32.

diZerega GS, Campeau JD: Peritoneal repair and post-surgical adhesion formation. Hum Reprod Update 2001; 7(6): 547-55PubMedCrossRef

33.

Reed KL, Fruin AB, Bishop-Bartolomei KK, Gower AC, Nicolau M, Stucchi AF, Leeman SE, Becker JM: Neurokinin-1 receptor and substance P messenger RNA levels increase during intraabdominal adhesion formation. J Surg Res 2002; 108(1): 165-72.PubMedCrossRef

34.

Di Filippo C, Falsetto A, De Pascale V, Tufariello E, De Lucia D, Rossi F, D’Amico M, Cennamo A: Plasma levels of t-PA and PAI-1 correlate with the formation of experimental post-surgical peritoneal adhesions. Mediators Inflamm 2006; 2006(4): 13901.PubMed

35.

Pirayesh A, Dur AH, Paauw NJ, Monstrey S, Kreis RW, Hoekstra MJ, Richters CD: Evaluation of acellular dermis for closure of abdominal wall defects in a rat model. Eur Surg Res 2008; 41(4): 346-52.PubMedCrossRef

36.

Hellebrekers BW, Kooistra T: Pathogenesis of postoperative adhesion formation. Br J Surg 2011; 98(11): 1503-16.PubMedCrossRef

37.

DiZerega GS: Use of adhesion barriers in pelvic reconstructive and gynecologic surgery. New York: Springer, 2000.

38.

Hellebrekers BW, Emeis JJ, Kooistra T, Trimbos JB, Moore NR Zwinderman KH, Trimbos-Kemper TC: A role for the fibrinolytic system in postsurgical adhesion formation. Fertil Steril 2005; 83(1): 122-9.PubMedCrossRef

39.

Holmdahl L, Eriksson E, Eriksson BI, Risberg B: Depression of peritoneal fibrinolysis during operation is a local response to trauma. Surgery 1998; 123(5): 539-44.PubMedCrossRef

40.

Scott-Coombes D, Whawell S, Vipond MN, Thompson J: Human intraperitoneal fibrinolytic response to elective surgery. Br J Surg 1995; 82(3): 414-7.PubMedCrossRef

41.

Wiseman DM, Trout JR, Diamond MP: The rates of adhesion development and the effects of crystalloid solutions on adhesion development in pelvic surgery. Fertil Steril 1998; 70(4): 702-11.PubMedCrossRef

42.

Hellebrekers BW, Trimbos-Kemper TC, Trimbos JB, Emeis JJ, Kooistra T: Use of fibrinolytic agents in the prevention of postoperative adhesion formation. Fertil Steril 2000; 74(2): 203-12.PubMedCrossRef

43.

Buckman RF, Woods M, Sargent L, Gervin AS: A unifying pathogenetic mechanism in the etiology of intraperitoneal adhesions. J Surg Res 1976; 20(1): 1-5.PubMedCrossRef

44.

Holmdahl L: Making and covering of surgical footprints. Lancet 1999; 353(9163): 1456-7.PubMedCrossRef

45.

Diamond MP, El-Hammady E, Munkarah A, Bieber EJ, Saed G: Modulation of the expression of vascular endothelial growth factor in human fibroblasts. Fertil Steril 2005; 83(2): 405-9.PubMedCrossRef

46.

Lucas PA, Warejcka DJ, Zhang LM, Newman WH, Young HE: Effect of rat mesenchymal stem cells on development of abdominal adhesions after surgery. J Surg Res 1996; 62(2): 229-32.PubMedCrossRef

47.

Thaler K, Mack JA, Berho M, Grotendorst G, Wexner SD, Abramson SR: Coincidence of connective tissue growth factor expression with fibrosis and angiogenesis in postoperative peritoneal adhesion formation. Eur Surg Res 2005; 37(4): 235-41.PubMedCrossRef

48.

Cahill RA, Redmond HP: Cytokine orchestration in post-operative peritoneal adhesion formation. World J Gastroenterol 2008; 14(31): 4861-6.PubMedCrossRef

49.

Gorvy DA, Herrick SE, Shah M, Ferguson MW: Experimental manipulation of transforming growth factor-beta isoforms significantly affects adhesion formation in a murine surgical model. Am J Pathol 2005; 167(4): 1005-19.PubMedCrossRef

50.

Henne-Bruns D, Holtig A, Tesch C, Kremer B: [Prevention of adhesions by intraperitoneal administration of substances in abdominal interventions]. Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir 1990: 1027-30.

51.

Singhal V, Li TC, Cooke ID: An analysis of factors influencing the outcome of 232 consecutive tubal microsurgery cases. Br J Obstet Gynaecol 1991; 98(7): 628-36.PubMedCrossRef

52.

Winston RM, Margara RA: Microsurgical salpingostomy is not an obsolete procedure. Br J Obstet Gynaecol 1991; 98(7): 637-42.PubMedCrossRef

53.

Robertson D, Lefebvre G, Leyland N, Wolfman W, Allaire C, Awadalla A, Best C, Contestabile E, Dunn S, Heywood M, Leroux N, Potestio F, Rittenberg D, Senikas V, Soucy R, Singh S: Adhesion prevention in gynaecological surgery. J Obstet Gynaecol Can 2010; 32(6): 598-608.PubMed

54.

Gonzalez-Quintero VH, Cruz-Pachano FE: Preventing adhesions in obstetric and gynecologic surgical procedures. Rev Obstet Gynecol 2009; 2(1): 38-45.PubMed

55.

Becker JM, Dayton MT, Fazio VW, Beck DE, Stryker SJ, Wexner SD, Wolff BG, Roberts PL, Smith LE, Sweeney SA, Moore M: Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study. J Am Coll Surg 1996; 183(4): 297-306.PubMed

56.

Menzies D: Peritoneal adhesions. Incidence, cause, and prevention. Surg Annu 1992; 24 Pt 1: 27-45.

57.

The Practice Committee of the American Society for Reproductive Medicine in collaboration with the Society of Reproductive Surgeons: pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgery. Fertil Steril 2007; 88(1): 21-6.

58.

Brill AI, Nezhat F, Nezhat CH, Nezhat C: The incidence of adhesions after prior laparotomy: a laparoscopic appraisal. Obstet Gynecol 1995; 85(2): 269-72.PubMedCrossRef

59.

Levrant SG, Bieber EJ, Barnes RB: Anterior abdominal wall adhesions after laparotomy or laparoscopy. J Am Assoc Gynecol Laparosc 1997; 4(3): 353-6.PubMedCrossRef

60.

Ott DE: Laparoscopy and tribology: the effect of laparoscopic gas on peritoneal fluid. J Am Assoc Gynecol Laparosc 2001; 8(1): 117-23.PubMedCrossRef

61.

Molinas CR, Koninckx PR: Hypoxaemia induced by CO(2) or helium pneumoperitoneum is a co-factor in adhesion formation in rabbits. Hum Reprod 2000; 15(8): 1758-63.PubMedCrossRef

62.

Yesildaglar N, Koninckx PR: Adhesion formation in intubated rabbits increases with high insufflation pressure during endoscopic surgery. Hum Reprod 2000; 15(3): 687-91.PubMedCrossRef

63.

Peng Y, Zheng M, Ye Q, Chen X, Yu B, Liu B: Heated and humidified CO₂ prevents hypothermia, peritoneal injury, and intra-abdominal adhesions during prolonged laparoscopic insufflations. J Surg Res 2009; 151(1): 40-7.PubMedCrossRef

64.

Bergstrom M, Falk P, Holmdahl L: CO₂ promotes plasminogen activator inhibitor type 1 expression in human mesothelial cells. Surg Endosc 2003; 17(11): 1818-22.PubMedCrossRef

65.

Cheong YC, Bajekal N, Li TC: Peritoneal closure—to close or not to close. Hum Reprod 2001; 16(8): 1548-52.PubMedCrossRef

66.

Lyell DJ, Caughey AB, Hu E, Daniels K: Peritoneal closure at primary cesarean delivery and adhesions. Obstet Gynecol 2005; 106(2): 275-80.PubMedCrossRef

67.

Roset E, Boulvain M, Irion O: Nonclosure of the peritoneum during caesarean section: long-term follow-up of a randomised controlled trial. Eur J Obstet Gynecol Reprod Biol 2003; 108(1): 40-4.PubMedCrossRef

68.

Tulandi T, Hum HS, Gelfand MM: Closure of laparotomy incisions with or without peritoneal suturing and second-look laparoscopy. Am J Obstet Gynecol 1988; 158(3 Pt 1): 536-7.PubMed

69.

Komoto Y, Shimoya K, Shimizu T, Kimura T, Hayashi S, Temma-Asano K, Kanagawa T, Fukuda H, Murata Y: Prospective study of non-closure or closure of the peritoneum at cesarean delivery in 124 women: impact of prior peritoneal closure at primary cesarean on the interval time between first cesarean section and the next pregnancy and significant adhesion at second cesarean. J Obstet Gynaecol Res 2006; 32(4): 396-402.PubMedCrossRef

70.

Cheong YC, Premkumar G, Metwally M, Peacock JL, Li TC: To close or not to close? A systematic review and a meta-analysis of peritoneal non-closure and adhesion formation after caesarean section. Eur J Obstet Gynecol Reprod Biol 2009; 147(1): 3-8.PubMedCrossRef

71.

Avsar FM, Sahin M, Aksoy F, Avsar AF, Akoz M, Hengirmen S, Bilici S: Effects of diphenhydramine HCl and methylprednisolone in the prevention of abdominal adhesions. Am J Surg 2001; 181(6): 512-5.PubMedCrossRef

72.

Sahin M, Cakir M, Avsar FM, Tekin A, Kucukkartallar T, Akoz M: The effects of anti-adhesion materials in preventing postoperative adhesion in abdominal cavity (anti-adhesion materials for postoperative adhesions). Inflammation 2007; 30(6): 244-9.PubMedCrossRef

73.

Muzii L, Marana R, Brunetti L, Margutti F, Vacca M, Mancuso S: Postoperative adhesion prevention with low-dose aspirin: effect through the selective inhibition of thromboxane production. Hum Reprod 1998; 13(6): 1486-9.PubMedCrossRef

74.

Oh SH, Kim JK, Song KS, Noh SM, Ghil SH, Yuk SH, Lee JH: Prevention of postsurgical tissue adhesion by anti-inflammatory drug-loaded pluronic mixtures with sol–gel transition behavior. J Biomed Mater Res A 2005; 72(3): 306-16.PubMed

75.

Rodgers KE, Johns DB, Girgis W, diZerega GS: Prevention of adhesion formation with intraperitoneal administration of tolmetin and hyaluronic acid. J Invest Surg 1997; 10(6): 367-73.PubMedCrossRef

76.

Aldemir M, Ozturk H, Erten C, Buyukbayram H: The preventive effect of Rofecoxib in postoperative intraperitoneal adhesions. Acta Chir Belg 2004; 104(1): 97-100.PubMed

77.

Fukasawa M, Girgis W, diZerega GS: Inhibition of postsurgical adhesions in a standardized rabbit model: II. Intraperitoneal treatment with heparin. Int J Fertil 1991; 36(5): 296-301.PubMed

78.

Kutlay J, Ozer Y, Isik B, Kargici H: Comparative effectiveness of several agents for preventing postoperative adhesions. World J Surg 2004; 28(7): 662-5.PubMedCrossRef

79.

Parsak CK, Satar S, Akcam T, Satar D, Sungur I: Effectiveness of treatment to prevent adhesions after abdominal surgery: an experimental evaluation in rats. Adv Ther 2007; 24(4): 796-802.PubMedCrossRef

80.

Dorr PJ, Vemer HM, Brommer EJ, Willemsen WN, Veldhuizen RW, Rolland R: Prevention of postoperative adhesions by tissue-type plasminogen activator (t-PA) in the rabbit. Eur J Obstet Gynecol Reprod Biol 1990; 37(3): 287-91.PubMedCrossRef

81.

Irkorucu O, Ferahkose Z, Memis L, Ekinci O, Akin M: Reduction of postsurgical adhesions in a rat model: a comparative study. Clinics (Sao Paulo) 2009; 64(2): 143-8.

82.

Kucuk HF, Kaptanoglu L, Kurt N, Uzun H, Eser M, Bingul S, Torlak OA, Akyol H: The role of simvastatin on postoperative peritoneal adhesion formation in an animal model. Eur Surg Res 2007; 39(2): 98-102.PubMedCrossRef

83.

Lalountas MA, Ballas KD, Skouras C, Asteriou C, Kontoulis T, Pissas D, Triantafyllou A, Sakantamis AK: Preventing intraperitoneal adhesions with atorvastatin and sodium hyaluronate/carboxymethylcellulose: a comparative study in rats. Am J Surg 2010; 200(1): 118-23.PubMedCrossRef

84.

Reid RL, Hahn PM, Spence JE, Tulandi T, Yuzpe AA, Wiseman DM: A randomized clinical trial of oxidized regenerated cellulose adhesion barrier (Interceed, TC7) alone or in combination with heparin. Fertil Steril 1997; 67(1): 23-9.PubMedCrossRef

85.

Kement M, Censur Z, Oncel M, Buyukokuroglu ME, Gezen FC: Heparin for adhesion prevention: comparison of three different dosages with Seprafilm in a murine model. Int J Surg 2011; 9(3): 225-8.PubMedCrossRef

86.

Jansen RP: Failure of peritoneal irrigation with heparin during pelvic operations upon young women to reduce adhesions. Surg Gynecol Obstet 1988; 166(2): 154-60.PubMed

87.

Metwally M, Gorvy D, Watson A, Li TC: Hyaluronic acid fluid agents for the prevention of adhesions after fertility-preserving gynecological surgery: a meta-analysis of randomized controlled trials. Fertil Steril 2007; 87(5): 1139-46.PubMedCrossRef

88.

Shah M, Foreman DM, Ferguson MW: Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 1992; 339(8787): 213-4.PubMedCrossRef

89.

Ferguson MW, O’Kane S: Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 2004; 359(1445): 839-50.PubMedCrossRef

90.

Reed KL, Stucchi AF, Leeman SE, Becker JM: Inhibitory effects of a neurokinin-1 receptor antagonist on postoperative peritoneal adhesion formation. Ann N Y Acad Sci 2008; 1144: 116-26.PubMedCrossRef

91.

Cheong YC, Shelton JB, Laird SM, Li TC, Ledger WL, Cooke ID: Peritoneal fluid concentrations of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta in women with pelvic adhesions. Fertil Steril 2003; 79(5): 1168-75.PubMedCrossRef

92.

Cohen PA, Gower AC, Stucchi AF, Leeman SE, Becker JM, Reed KL: A neurokinin-1 receptor antagonist that reduces intraabdominal adhesion formation increases peritoneal matrix metalloproteinase activity. Wound Repair Regen 2007; 15(6): 800-8.PubMedCrossRef

93.

Lim R, Morrill JM, Prushik SG, Reed KL, Gower AC, Leeman SE, Stucchi AF, Becker JM: An FDA approved neurokinin-1 receptor antagonist is effective in reducing intraabdominal adhesions when administered intraperitoneally, but not orally. J Gastrointest Surg 2008; 12(10): 1754-61.PubMedCrossRef

94.

Prushik SG, Aarons CB, Matteotti R, Reed KL, Gower AC, Leeman SE, Stucchi AF, Becker JM: A neurokinin 1 receptor antagonist decreases adhesion reformation after laparoscopic lysis of adhesions in a rat model of adhesion formation. Surg Endosc 2007; 21(10): 1790-5.PubMedCrossRef

95.

Reed KL, Heydrick SJ, Aarons CB, Prushik S, Gower AC, Stucchi AF, Becker JM: A neurokinin-1 receptor antagonist that reduces intra-abdominal adhesion formation decreases oxidative stress in the peritoneum. Am J Physiol Gastrointest Liver Physiol 2007; 293(3): G544-51.PubMedCrossRef

96.

Reed KL, Fruin AB, Gower AC, Stucchi AF, Leeman SE, Becker JM: A neurokinin 1 receptor antagonist decreases postoperative peritoneal adhesion formation and increases peritoneal fibrinolytic activity. Proc Natl Acad Sci U S A 2004; 101(24): 9115-20.PubMedCrossRef

97.

Lim R, Stucchi AF, Morrill JM, Reed KL, Lynch R, Becker JM: The efficacy of a hyaluronate-carboxymethylcellulose bioresorbable membrane that reduces postoperative adhesions is increased by the intra-operative co-administration of a neurokinin 1 receptor antagonist in a rat model. Surgery 2010; 148(5): 991-9.PubMedCrossRef

98.

Yeo Y, Kohane DS: Polymers in the prevention of peritoneal adhesions. Eur J Pharm Biopharm 2008; 68(1): 57-66.PubMedCrossRef

99.

Brochhausen C, Schmitt VH, Wiedenroth CB, Krämer, B, Rajab, TK, Wallwiener M, Wallwiener C, Wallwiener D, Planck H, Kirkpatrick CJ: Remesothelialization of a polylactide-based membrane for the prevention of peritoneal adhesions. Eur Cell Mat 2008; 16(1): 26.

100.

Brochhausen C, Krämer B, Rajab TK, Schmitt VH, Wallwiener M, Wallwiener C, Zehbe R, Hierlemann H, Planck CNE, Wallwiener D, Kirkpatrick CJ: First results of the remesothelialization of a polylactide based foil for peritoneal adhesion. BIOmaterialien 2007; 8: 150.

101.

Rajab TK, Wallwiener M, Planck C, Brochhausen C, Kraemer B, Wallwiener CW: A direct comparison of seprafilm, adept, intercoat, and spraygel for adhesion prophylaxis. J Surg Res 2010; 161(2): 246-9.PubMedCrossRef

102.

Brown CB, Luciano AA, Martin D, Peers E, Scrimgeour A, diZerega GS: Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomized, controlled study. Fertil Steril 2007; 88(5): 1413-26.PubMedCrossRef

103.

Verco SJS, Brown CB: Peritoneal adhesions: problems and solutions. Eur. Pharm. Contractor 2000; August: 74-81.

104.

diZerega GS: Contemporary adhesion prevention. Fertil Steril 1994; 61(2): 219-35PubMed

105.

DiZerega GS, Campeau JD: Use of instillates to prevent intraperitoneal adhesions: crystalloids and dextran. Infertil Reprod Med Clinics North Am 1994; 5: 463-78.

106.

Ellis H, Harrison W, Hugh TB: The healing of peritoneum under normal and pathological conditions. Br J Surg 1965; 52: 471-6.PubMedCrossRef

107.

Metwally M, Watson A, Lilford R, Vandekerckhove P: Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev 2006(2): CD001298.

108.

Hart R, Magos A: Laparascopically instilled fluid: the rate of absorption and the effects on patient comfort and fluid balance. Gyneacol Endocs 1996; 5: 287-91.CrossRef

109.

Hellebrekers BW, Trimbos-Kemper GC, van Blitterswijk CA, Bakkum EA, Trimbos JB: Effects of five different barrier materials on postsurgical adhesion formation in the rat. Hum Reprod. 2000; 15(6): 1358-63.PubMedCrossRef

110.

Shear L, Swartz C, Shinaberger JA, Barry KG: Kinetics of peritoneal fluid absorption in adult man. N Engl J Med 1965; 272: 123-7.PubMedCrossRef

111.

diZerega GS, Verco SJ, Young P, Kettel M, Kobak W, Martin D, Sanfilippo J, Peers EM, Scrimgeour A, Brown CB: A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Hum Reprod 2002; 17(4): 1031-8PubMedCrossRef

112.

Menzies D, Pascual MH, Walz MK, Duron JJ, Tonelli F, Crowe A, Knight A: Use of icodextrin 4% solution in the prevention of adhesion formation following general surgery: from the multicentre ARIEL Registry. Ann R Coll Surg Engl 2006; 88(4): 375-82.PubMedCrossRef

113.

Catena F, Ansaloni L, Di Saverio S, Pinna AD: P.O.P.A. study: prevention of postoperative abdominal adhesions by icodextrin 4% solution after laparotomy for adhesive small bowel obstruction. A prospective randomized controlled trial. J Gastrointest Surg 2012; 16(2): 382-8.

114.

Tepetes K, Asprodini EK, Christodoulidis G, Spyridakis M, Kouvaras E, Hatzitheofilou K: Prevention of postoperative adhesion formation by individual and combined administration of 4 per cent icodextrin and dimetindene maleate. Br J Surg 2009; 96(12): 1476-83.PubMedCrossRef

115.

Schnuriger B, Barmparas G, Branco BC, Lustenberger T, Inaba K, Demetriades D: Prevention of postoperative peritoneal adhesions: a review of the literature. Am J Surg 2011; 201(1): 111-21.PubMedCrossRef

116.

Hosie K, Gilbert JA, Kerr D, Brown CB, Peers EM: Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin. Drug Deliv 2001; 8(1): 9-12.PubMedCrossRef

117.

Dobbie JW, Gilbert JA: Intraperitoneal drug delivery systems. Eur. Pharm. Contractor 1999; May: 44-8.

118.

Gilbert JA, Peers EM, Brown CB: IP chemotherapy using icodextrin. Perit. Dial. Int. 1999; 19(1): 78.

119.

Gilbert JA, Peers EM, Brown CB: IP drug delivery in cancer and AIDS, using icodextrin (ICO). Perit. Dial. Int. 1999; 19(1): 79.

120.

Lüllmann-Rauch R: Histologie. Stuttgart: Thieme, 2003

121.

Ustun C, Kocak I, Akpolat I: Effects of seprafilm (sodium hyaluranate-based bioresorbable), Sepracoat (0.4% hyaluronic acid), and Ringer’s lactate on the prevention of postsurgical adhesion formation in rat models. J Obstet Gynaecol 2000; 20(1): 78-80PubMedCrossRef

122.

Diamond MP: Reduction of de novo postsurgical adhesions by intraoperative precoating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group. Fertil Steril 1998; 69(6): 1067-74.PubMedCrossRef

123.

Lundorff P, van Geldorp H, Tronstad SE, Lalos O, Larrson B, Johns DB, DiZerega GS: Reduction of post-surgical adhesions with ferric hyaluronate gel: a European study. Hum Reprod 2001; 16(9): 1982-8.PubMedCrossRef

124.

Roman H, Canis M, Kamble M, Botchorishvili R, Pouly JL, Mage G: Efficacy of three adhesion-preventing agents in reducing severe peritoneal trauma induced by bipolar coagulation in a laparoscopic rat model. Fertil Steril 2005; 83 Suppl 1: 1113-8.PubMedCrossRef

125.

Tang CL, Jayne DG, Seow-Choen F, Ng YY, Eu KW, Mustapha N: A randomized controlled trial of 0.5% ferric hyaluronate gel (Intergel) in the prevention of adhesions following abdominal surgery. Ann Surg 2006; 243(4): 449-55.PubMedCrossRef

126.

Wiseman DM: Registries for anti-adhesion products? Fertil Steril 2006; 85(4): e7; author reply e8.PubMedCrossRef

127.

Caballero J, Tulandi T: Effects of Ringer’s lactate and fibrin glue on postsurgical adhesions. J Reprod Med 1992; 37(2): 141-3.PubMed

128.

Meek K, de Virgilio C, Murrell Z, Karamatsu M, Stabile B, Amin S, Sandoval M, French S, Pierre K: Inhibition of intra-abdominal adhesions: a comparison of hemaseel APR and cryoprecipitate fibrin glue. J Invest Surg 2001; 14(4): 227-33.PubMedCrossRef

129.

de Virgilio C, Dubrow T, Sheppard BB, MacDonald WD, Nelson RJ, Lesavoy MA, Robertson JM: Fibrin glue inhibits intra-abdominal adhesion formation. Arch Surg 1990; 125(10): 1378-81; discussion 1381-2.

130.

Kjaergard HK: Patient-derived fibrin sealant: clinical, preclinical, and biophysical aspects. Dan Med Bull 2003; 50(4): 293-309.PubMed

131.

Ferland R, Campbell PK: Pre-clinical evaluation of a next-generation spray adhesion barrier for multiple site adhesion protection. Surg Technol Int 2009; 18: 137-43.PubMed

132.

SprayShield versus SprayGel. 2011. Available at: www.SprayShield.de. Accessed November 17, 2011.

133.

SprayShield™—new adhesions barrier to prevent adhesions formation after surgical procedures. 2011. Available at: www.SprayShield.net. Accessed November 17, 2011.

134.

Mettler L, Audebert A, Lehmann-Willenbrock E, Schive-Peterhansl K, Jacobs VR: A randomized, prospective, controlled, multicenter clinical trial of a sprayable, site-specific adhesion barrier system in patients undergoing myomectomy. Fertil Steril 2004; 82(2): 398-404.PubMedCrossRef

135.

Hills BA: Role of surfactant in peritoneal dialysis. Perit Dial Int 2000; 20(5): 503-15.PubMed

136.

Muller SA, Treutner KH, Anurov M, Titkova S, Oettinger AP, Schumpelick V: Experimental evaluation of phospholipids and icodextrin in re-formation of peritoneal adhesions. Br J Surg 2003; 90(12): 1604-7.PubMedCrossRef

137.

Snoj M, Ar’Rajab A, Ahren B, Bengmark S: Effect of phosphatidylcholine on postoperative adhesions after small bowel anastomosis in the rat. Br J Surg 1992; 79(5): 427-9.PubMedCrossRef

138.

Butz N, Muller SA, Treutner KH, Anurov M, Titkova S, Oettinger AP, Schumpelick V: The influence of blood on the efficacy of intraperitoneally applied phospholipids for prevention of adhesions. BMC Surg 2007; 7: 14.PubMedCrossRef

139.

Muller SA, Treutner KH, Haase G, Kinzel S, Tietze L, Schumpelick V: Effect of intraperitoneal antiadhesive fluids in a rat peritonitis model. Arch Surg 2003; 138(3): 286-90.PubMedCrossRef

140.

Kim KD, Wang JC, Robertson DP, Brodke DS, Olson EM, Duberg AC, BenDebba M, Block KM, DiZerega GS: Reduction of radiculopathy and pain with Oxiplex/SP gel after laminectomy, laminotomy, and discectomy: a pilot clinical study. Spine (Phila Pa 1976) 2003; 28(10): 1080-7; discussion 1087-8.

141.

Kim KD, Wang JC, Robertson DP, Brodke DS, BenDebba M, Block KM, DiZerega GS: Reduction of leg pain and lower-extremity weakness for 1 year with Oxiplex/SP gel following laminectomy, laminotomy, and discectomy. Neurosurg Focus 2004; 17(1): ECP1PubMedCrossRef

142.

Rodgers KE, Robertson JT, Espinoza T, Oppelt W, Cortese S, DiZerega GS, Berg RA: Reduction of epidural fibrosis in lumbar surgery with Oxiplex adhesion barriers of carboxymethylcellulose and polyethylene oxide. Spine J 2003; 3(4): 277-83; discussion 284PubMedCrossRef

143.

Wiseman DM: Polymers for the prevention of surgical adhesions. In: Domb AJ (ed) Polymeric site-specific pharmacotherapy. New York: Wiley, 1994; 370-400.

144.

Amiji MM, Park K: Surface modification of polymeric biomaterials with PEO, a steric repulsion approach. Polymers of Biological and Bioclinical Significance. ACS Symposium Series 540. Washington, DC: American Chemical Society, 1994; Ch 11: 134–46.

145.

Arakawa T, Timasheff SN: Mechanism of poly(ethylene glycol) interaction with proteins. Biochemistry 1985; 24(24): 6756-62.PubMedCrossRef

146.

diZerega GS: Peritoneum, peritoneal healing, and adhesion formation. In: diZerega GS (ed) Peritoneal surgery. New York: Springer, 2000; 3–37CrossRef

147.

Gölander CG, Herron JN, Claesson KL, Stenius P, Andrade JD: Properties of immobilized PEG films and the interaction with proteins: experiments and modeling. In: Harris JM (ed) Poly (ethylene glycol) chemistry: biotechnical and biomedical applications. New York: Plenum, 1992; 221–245

148.

Liu LS, Berg RA: Adhesion barriers of carboxymethylcellulose and polyethylene oxide composite gels. J Biomed Mater Res 2002; 63(3): 326-32.PubMedCrossRef

149.

Kurt G, Cemil B, Celik B, Durdag E, Erdem O, Ceviker N: Comparison of Oxiplex and Gore-Tex effectivity in an experimental peridural fibrosis model. Neurocirugia (Astur) 2009; 20(4): 360-6.

150.

Robertson JT, Blackmore J, Oppelt W, Smith JS, diZerega GS, Rodgers KE: Reduction of peridural fibrosis by Oxiplex after laminectomy in a rabbit model. Presented at the American Association of Neurosurgeons Annual Meeting. Toronto, Canada, 21 April 2001.

151.

Rodgers KE, Schwartz HE, Roda N, Thornton M, Kobak W, diZerega GS: Effect of oxiplex* films (PEO/CMC) on adhesion formation and reformation in rabbit models and on peritoneal infection in a rat model. Fertil Steril 2000; 73(4): 831-8.PubMedCrossRef

152.

Lundorff P, Donnez J, Korell M, Audebert AJ, Block K, diZerega GS: Clinical evaluation of a viscoelastic gel for reduction of adhesions following gynaecological surgery by laparoscopy in Europe. Hum Reprod 2005; 20(2): 514-20.PubMedCrossRef

153.

Schonman R, Corona R, Bastidas A, De Cicco C, Mailova K, Koninckx PR: Intercoat gel (oxiplex): efficacy, safety, and tissue response in a laparoscopic mouse model. J Minim Invasive Gynecol 2009; 16(2): 188-94.PubMedCrossRef

154.

Yeung PP, Jr., Shwayder J, Pasic RP: Laparoscopic management of endometriosis: comprehensive review of best evidence. J Minim Invasive Gynecol 2009; 16(3): 269-81PubMedCrossRef

155.

Young P, Johns A, Templeman C, Witz C, Webster B, Ferland R, Diamond MP, Block K, DiZerega GS: Reduction of postoperative adhesions after laparoscopic gynecological surgery with Oxiplex/AP Gel: a pilot study. Fertil Steril 2005; 84(5): 1450-6.PubMedCrossRef

156.

Di Spiezio Sardo A, Spinelli M, Bramante S, Scognamiglio M, Greco E, Guida M, Cela V, Nappi C: Efficacy of a polyethylene oxide-sodium carboxymethylcellulose gel in prevention of intrauterine adhesions after hysteroscopic surgery. J Minim Invasive Gynecol 2011; 18(4): 462-9.PubMedCrossRef

157.

Moreira H, Jr., Wexner SD, Yamaguchi T, Pikarsky AJ, Choi JS, Weiss EG, Nogueras JJ, Sardinha TC, Billotti VL: Use of bioresorbable membrane (sodium hyaluronate + carboxymethylcellulose) after controlled bowel injuries in a rabbit model. Dis Colon Rectum 2000; 43(2): 182-7PubMedCrossRef

158.

Beck DE, Cohen Z, Fleshman JW, Kaufman HS, van Goor H, Wolff BG: A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Dis Colon Rectum 2003; 46(10): 1310-9.PubMedCrossRef

159.

Kusunoki M, Ikeuchi H, Yanagi H, Noda M, Tonouchi H, Mohri Y, Uchida K, Inoue Y, Kobayashi M, Miki C, Yamamura T: Bioresorbable hyaluronate-carboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial. Surg Today 2005; 35(11): 940-5.PubMedCrossRef

160.

Diamond MP: Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Seprafilm Adhesion Study Group. Fertil Steril 1996; 66(6): 904-10.PubMed

161.

Vrijland WW, Tseng LN, Eijkman HJ, Hop WC, Jakimowicz JJ, Leguit LP, Swank DJ, Haverlag R, Bonjer HJ, Jeekel H: Fewer intraperitoneal adhesions with use of hyaluronic acid-carboxymethylcellulose membrane: a randomized clinical trial. Ann Surg 2002; 235(2): 193-9.PubMedCrossRef

162.

van der Wal JB, Iordens GI, Vrijland WW, van Veen RN, Lange J, Jeekel J: Adhesion prevention during laparotomy: long-term follow-up of a randomized clinical trial. Ann Surg 2011; 253(6): 1118-21.PubMedCrossRef

163.

Fazio VW, Cohen Z, Fleshman JW, van Goor H, Bauer JJ, Wolff BG, Corman M, Beart RW Jr, Wexner SD, Becker JM, Monson JR, Kaufman HS, Beck DE, Bailey HR, Ludwig KA, Stamos MJ, Darzi A, Bleday R, Dorazio R, Madoff RD, Smith LE, Gearhart S, Lillemoe K, Gohl J: Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum 2006; 49(1): 1-11PubMedCrossRef

164.

Mohri Y, Uchida K, Araki T, Inoue Y, Tonouchi H, Miki C, Kunsunoki M: Hyaluronic acid-carboxycellulose membrane (Seprafilm) reduces early postoperative small bowel obstruction in gastrointestinal surgery. Am Surg 2005; 71(10): 861-3.PubMed

165.

Ahmad G, Duffy JM, Farquhar C, Vail A, Vandekerckhove P, Watson A, Wiseman D: Barrier agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev 2008(2): CD000475.

166.

Kumar S, Wong PF, Leaper DJ: Intra-peritoneal prophylactic agents for preventing adhesions and adhesive intestinal obstruction after non-gynaecological abdominal surgery. Cochrane Database Syst Rev 2009(1): CD005080.

167.

Lim R, Morrill JM, Lynch RC, Reed KL, Gower AC, Leeman SE, Stucchi AF, Becker JM: Practical limitations of bioresorbable membranes in the prevention of intra-abdominal adhesions. J Gastrointest Surg 2009; 13(1): 35-41; discussion 41-2PubMedCrossRef

168.

Greenawalt KE, Colt MJ, Corazzini RL, Krauth MC, Holmdahl L: A membrane slurry reduces postoperative adhesions in rat models of abdominal surgery. J Surg Res 2011; 168(1): e25-30.PubMedCrossRef

169.

Chu DI, Stucchi AF, Becker JM: A “solution” to the application of an effective physical barrier for the prevention of intra-abdominal adhesions. J Surg Res 2011; 167(1): 33-6.PubMedCrossRef

170.

Fenton BW, Fanning J: Laparoscopic application of hyaluronate/carboxymethylcellulose slurry: an adhesion barrier in a slurry formulation goes where the available sheets cannot. Am J Obstet Gynecol 2008; 199(3): 325 e1PubMedCrossRef

171.

Ortiz MV, Awad ZT: An easy technique for laparoscopic placement of Seprafilm. Surg Laparosc Endosc Percutan Tech 2009; 19(5): e181-3.PubMedCrossRef

172.

Lipetskaia L, Silver DF: Laparoscopic use of a hyaluronic acid carboxycellulose membrane slurry in gynecological oncology. Jsls 2010; 14(1): 91-4.PubMedCrossRef

173.

Suresh A, Celso BG, Awad ZT: Seprafilm slurry does not increase complication rates after laparoscopic colectomy. Surg Endosc 2011; 25(8): 2661-5.PubMedCrossRef

174.

Sheldon HK, Gainsbury ML, Cassidy MR, Chu DI, Stucchi AF, Becker JM: A sprayable hyaluronate/carboxymethylcellulose adhesion barrier exhibits regional adhesion reduction efficacy and does not impair intestinal healing. J Gastrointest Surg 2012; 16(2): 325-33.

175.

Fossum GT, Silverberg KM, Miller CE, Diamond MP, Holmdahl L: Gynecologic use of Sepraspray adhesion barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study. Fertil Steril 2011; 96(2): 487-91.PubMedCrossRef

176.

Diamond MP: Animal adhesion models: design, variables and relevance. Pelvic surgery. Heidelberg: Springer, 1997; 65–70

177.

Franklin RR: Reduction of ovarian adhesions by the use of Interceed. Ovarian Adhesion Study Group. Obstet Gynecol 1995; 86(3): 335-40.PubMedCrossRef

178.

Azziz R: Microsurgery alone or with INTERCEED Absorbable Adhesion Barrier for pelvic sidewall adhesion re-formation. The INTERCEED (TC7) Adhesion Barrier Study Group II. Surg Gynecol Obstet 1993; 177(2): 135-9PubMed

179.

Sekiba K: Use of Interceed (TC7) absorbable adhesion barrier to reduce postoperative adhesion reformation in infertility and endometriosis surgery. The Obstetrics and Gynecology Adhesion Prevention Committee. Obstet Gynecol 1992; 79(4): 518-22.PubMed

180.

Wiseman DM, Gottlick-Iarkowski L, Kamp L: Effect of different barriers of oxidized regenerated cellulose (ORC) on cecal and sidewall adhesions in the presence and absence of bleeding. J Invest Surg 1999; 12(3): 141-6.PubMedCrossRef

181.

Uhlig C, Rapp M, Hartmann B, Hierlemann H, Planck H, Dittel KK: Suprathel—an innovative, resorbable skin substitute for the treatment of burn victims. Burns 2007; 33(2): 221-9.PubMedCrossRef

182.

Schwarze H, Kuntscher M, Uhlig C, Hierlemann H, Prantl L, Ottomann C, Hartmann B: Suprathel, a new skin substitute, in the management of partial-thickness burn wounds: results of a clinical study. Ann Plast Surg 2008; 60(2): 181-5.PubMedCrossRef

183.

Kraemer B, Wallwiener M, Brochhausen C, Planck CNE, Hierlemann H, Isaacson KB, Rajab TK, Wallwiener C: A pilot study of laparoscopic adhesion prophylaxis after myomectomy with a copolymer designed for endoscopic application. J Minim Invasive Gynecol 2010; 17(2): 222-7.PubMedCrossRef

184.

Rajab TK, Wallwiener CW, Brochhausen C, Hierlemann H, Kraemer B, Wallwiener M: Adhesion prophylaxis using a copolymer with rationally designed material properties. Surgery 2009; 145(2): 196-201.PubMedCrossRef

185.

Magro B, Mita P, Bracco GL, Coccia E, Scarselli G: Expanded polytetrafluoroethylene surgical membrane in ovarian surgery on the rabbit. Biocompatibility, adhesion prevention properties and ability to preserve reproductive capacity. J Reprod Med 1996; 41(2): 73-8.PubMed

186.

Haney AF, Hesla J, Hurst BS, Kettel LM, Murphy AA, Rock JA, Rowe G, Schlaff WD: Expanded polytetrafluoroethylene (Gore-Tex Surgical Membrane) is superior to oxidized regenerated cellulose (Interceed TC7+) in preventing adhesions. Fertil Steril 1995; 63(5): 1021-6.PubMed

187.

Okuyama N, Rodgers KE, Wang CY, Girgis W, Oz M, St Amand K, Pines E, DeCherney AH, Rose EA, Cohn D, DiZerega GS: Prevention of retrosternal adhesion formation in a rabbit model using bioresorbable films of polyethylene glycol and polylactic acid. J Surg Res 1998; 78(2): 118-22.PubMedCrossRef

188.

Schreiber C, Boening A, Kostolny M, Pines E, Cremer J, Lange R, Scheewe J: European clinical experience with REPEL-CV. Expert Rev Med Devices 2007; 4(3): 291-5.PubMedCrossRef

189.

Okuyama N, Wang CY, Rose EA, Rodgers KE, Pines E, DiZerega GS, Oz MC: Reduction of retrosternal and pericardial adhesions with rapidly resorbable polymer films. Ann Thorac Surg 1999; 68(3): 913-8.PubMedCrossRef

190.

Rodgers K, Cohn D, Hotovely A, Pines E, Diamond MP, diZerega G: Evaluation of polyethylene glycol/polylactic acid films in the prevention of adhesions in the rabbit adhesion formation and reformation sidewall models. Fertil Steril 1998; 69(3): 403-8.PubMedCrossRef

191.

Butler CE, Prieto VG: Reduction of adhesions with composite AlloDerm/polypropylene mesh implants for abdominal wall reconstruction. Plast Reconstr Surg 2004; 114(2): 464-73.PubMedCrossRef

192.

Gonzalez R, Rodeheaver GT, Moody DL, Foresman PA, Ramshaw BJ: Resistance to adhesion formation: a comparative study of treated and untreated mesh products placed in the abdominal cavity. Hernia 2004; 8(3): 213-9.PubMedCrossRef

193.

de Araujo UR, Czeczko NG, Ribas-Filho JM, Malafaia O, Budel VM, Balderrama CM, Zimmermann E, Dietz UA: Intraperitoneal meshes in the repair of abdominal wall defects: comparison of polyester with collagen versus polypropylene with polyglycolic acid. Rev Col Bras Cir 2009; 36(3): 241-9.PubMedCrossRef

194.

Judge TW, Parker DM, Dinsmore RC: Abdominal wall hernia repair: a comparison of sepramesh and parietex composite mesh in a rabbit hernia model. J Am Coll Surg 2007; 204(2): 276-81.PubMedCrossRef

195.

Hsu PW, Salgado CJ, Kent K, Finnegan M, Pello M, Simons R, Atabek U, Kann B: Evaluation of porcine dermal collagen (Permacol) used in abdominal wall reconstruction. J Plast Reconstr Aesthet Surg 2009; 62(11): 1484-9.PubMedCrossRef

196.

Loganathan A, Ainslie WG, Wedgwood KR: Initial evaluation of Permacol bioprosthesis for the repair of complex incisional and parastomal hernias. Surgeon 2010; 8(4): 202-5.PubMedCrossRef

197.

Bellon JM, Rodriguez M, Garcia-Honduvilla N, Pascual G, Gomez Gil V, Bujan J: Peritoneal effects of prosthetic meshes used to repair abdominal wall defects: monitoring adhesions by sequential laparoscopy. J Laparoendosc Adv Surg Tech A 2007; 17(2): 160-6PubMedCrossRef

198.

Bellon JM, Rodriguez M, Gomez-Gil V, Sotomayor S, Bujan J, Pascual G: Postimplant intraperitoneal behavior of collagen-based meshes followed by laparoscopy. Surg Endosc 2012; 26(1): 27-35.

199.

Ansaloni L, Catena F, Coccolini F, Fini M, Gazzotti F, Giardino R, Pinna AD: Peritoneal adhesions to prosthetic materials: an experimental comparative study of treated and untreated polypropylene meshes placed in the abdominal cavity. J Laparoendosc Adv Surg Tech A 2009; 19(3): 369-74.PubMedCrossRef

200.

Abraham LC, Zuena E, Perez-Ramirez B, Kaplan DL: Guide to collagen characterization for biomaterial studies. J Biomed Mater Res B Appl Biomater 2008; 87(1): 264-85.PubMed

201.

Karpelowsky JS, Millar AJ: Porcine dermal collagen (Permacol) for chest and abdominal wall reconstruction in thoraco-omphalopagus conjoined twin separation. Pediatr Surg Int 2010; 26(3): 315-8.PubMedCrossRef

202.

Pentlow A, Smart NJ, Richards SK, Inward CD, Morgan JD: The use of porcine dermal collagen implants in assisting abdominal wall closure of pediatric renal transplant recipients with donor size discrepancy. Pediatr Transplant 2008; 12(1): 20-3.PubMedCrossRef

203.

Stanwix MG, Nam AJ, Hui-Chou HG, Ferrari JP, Aberman HM, Hawes ML, Keledjian KM, Jones LS, Rodriguez ED: Abdominal ventral hernia repair with current biological prostheses: an experimental large animal model. Ann Plast Surg 2011; 66(4): 403-9.PubMedCrossRef

204.

van’t Riet M, Burger JW, Bonthuis F, Jeekel J, Bonjer HJ: Prevention of adhesion formation to polypropylene mesh by collagen coating: a randomized controlled study in a rat model of ventral hernia repair. Surg Endosc 2004; 18(4): 681-5CrossRef

205.

Gaertner WB, Bonsack ME, Delaney JP: Experimental evaluation of four biologic prostheses for ventral hernia repair. J Gastrointest Surg 2007; 11(10): 1275-85.PubMedCrossRef

206.

Ayubi FS, Armstrong PJ, Mattia MS, Parker DM: Abdominal wall hernia repair: a comparison of Permacol and Surgisis grafts in a rat hernia model. Hernia 2008; 12(4): 373-8.PubMedCrossRef

207.

Rodriguez M, Pascual G, Sotomayor S, Perez-Kohler B, Cifuentes A, Bellon JM: Chemical adhesion barriers: do they affect the intraperitoneal behavior of a composite mesh? J Invest Surg 2011; 24(3): 115-22.PubMedCrossRef

208.

Schonleben F, Reck T, Tannapfel A, Hohenberger W, Schneider I: Collagen foil (TissuFoil E) reduces the formation of adhesions when using polypropylene mesh for the repair of experimental abdominal wall defects. Int J Colorectal Dis 2006; 21(8): 840-6.PubMedCrossRef

209.

Schreinemacher MH, Emans PJ, Gijbels MJ, Greve JW, Beets GL, Bouvy ND: Degradation of mesh coatings and intraperitoneal adhesion formation in an experimental model. Br J Surg 2009; 96(3): 305-13.PubMedCrossRef

210.

Cervantes-Sanchez CR, Olaya E, Testas M, Garcia-Lopez N, Coste G, Arrellin G, Luna A, Krotzsch FE: Collagen-PVP, a collagen synthesis modulator, decreases intraperitoneal adhesions. J Surg Res 2003; 110(1): 207-10.PubMedCrossRef

211.

Jin J, Voskerician G, Hunter SA, McGee MF, Cavazzola LT, Schomisch S, Harth K, Rosen MJ: Human peritoneal membrane controls adhesion formation and host tissue response following intra-abdominal placement in a porcine model. J Surg Res 2009; 156(2): 297-304.PubMedCrossRef

212.

Edwards GA, Glattauer V, Nash TJ, White TJ, Brock KA, Werkmeister JA, Ramshaw JA: In vivo evaluation of a collagenous membrane as an absorbable adhesion barrier. J Biomed Mater Res 1997; 34(3): 291-7.PubMedCrossRef

213.

Hoffmann NE, Siddiqui SA, Agarwal S, McKellar SH, Kurtz HJ, Gettman MT, Ereth MH: Choice of hemostatic agent influences adhesion formation in a rat cecal adhesion model. J Surg Res 2009; 155(1): 77-81.PubMedCrossRef

214.

Petter-Puchner AH, Fortelny RH, Walder N, Mittermayr R, Ohlinger W, van Griensven M, Redl H: Adverse effects associated with the use of porcine cross-linked collagen implants in an experimental model of incisional hernia repair. J Surg Res 2008; 145(1): 105-10.PubMedCrossRef

215.

Hammond TM, Chin-Aleong J, Navsaria H, Williams NS: Human in vivo cellular response to a cross-linked acellular collagen implant. Br J Surg 2008; 95(4): 438-46.PubMedCrossRef

216.

Connolly RJ: Evaluation of a unique bovine collagen matrix for soft tissue repair and reinforcement. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17 Suppl 1: S44-7.PubMed

217.

Wilshaw SP, Burke D, Fisher J, Ingham E: Investigation of the antiadhesive properties of human mesothelial cells cultured in vitro on implantable surgical materials. J Biomed Mater Res B Appl Biomater 2009; 88(1): 49-60.PubMed

218.

Kuga H, Morisaki T, Nakamura K, Onishi H, Matsuda T, Sueishi K, Tanaka M, Katano M: Construction of a transplantable tissue-engineered artificial peritoneum. Eur Surg Res 2004; 36(5): 323-30.PubMedCrossRef

219.

Gruber-Blum S, Petter-Puchner AH, Brand J, Fortelny RH, Walder N, Oehlinger W, Koenig F, Redl H: Comparison of three separate antiadhesive barriers for intraperitoneal onlay mesh hernia repair in an experimental model. Br J Surg 2011; 98(3): 442-9.PubMedCrossRef

220.

Karacam V, Onen A, Sanli A, Gurel D, Kargi A, Karapolat S, Ozdemir N: Prevention of pleural adhesions using a membrane containing polyethylene glycol in rats. Int J Med Sci 2011; 8(5): 380-6.PubMedCrossRef

221.

Canis M, Benifla JL, Tayrac R, Tiropon G, Darai E, Madelenat P, Leveque J, Fernandez H, Panel P, Descamps P, Audebert A, Castaing N: Results of a comparative randomized study in adhesion prevention: second-look evaluation shows significant results of PREVADH adhesion barrier. Gynecol Surg 2009; 6(1): 71–125.CrossRef

222.

Mabrut JY, Favre JP, Desrousseaux B, Chipponi J, Arnaud JP, Duffas JP, Fourtanier G, Flament JB, Gouillat C, Berdah S, Mantion G, Fagniez PL, Champault G, Baulieux J: Safety and long-term outcome of a new concept for surgical adhesion-reduction strategies (Prevadh): a prospective, multicenter study. Hepatogastroenterology 2008; 55(82-83): 517-21.PubMed

223.

diZerega GS, Tulandi T: Prevention of intra-abdominal adhesions in gynaecological surgery. Reprod Biomed Online 2008; 17(3): 303-6.PubMedCrossRef

224.

Wallwiener CW, Kraemer B, Wallwiener M, Brochhausen C, Isaacson KB, Rajab TK: The extent of adhesion induction through electrocoagulation and suturing in an experimental rat study. Fertil Steril 2010; 93(4): 1040-4.

225.

Brochhausen C, Schmitt VH, Rajab TK, Planck CNE, Krämer B, Wallwiener C, Wallwiener M, Wallwiener D, Planck H, Kirkpatrick CJ: Prevention of peritoneal adhesions by different barriers in a rat model—an histological and scanning electron microscopical study. Der Pathologe 2009; 30(1): 39.

226.

Schmitt VH, Brochhausen C, Planck CNE, Krämer B, Wallwiener M, Hierlemann H, Wallwiener D, Planck H, Kirkpatrick CJ: Different barriers for the prevention of peritoneal adhesions—a histological and scanning electron microscopical study. BIOmaterialien 2009; 10: 147.

227.

Joseph J, Mohanty M, Mohanan PV: Role of immune cells and inflammatory cytokines in regulation of fibrosis around silicone expander implants. J Mater Sci Mater Med 2010; 21(5): 1665-76.PubMedCrossRef

228.

Tan H, Ramirez CM, Miljkovic N, Li H, Rubin JP, Marra KG: Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering. Biomaterials 2009; 30(36): 6844-53.PubMedCrossRef

229.

Cui Z, Lee BH, Pauken C, Vernon BL: Degradation, cytotoxicity, and biocompatibility of NIPAAm-based thermosensitive, injectable, and bioresorbable polymer hydrogels. J Biomed Mater Res A 2011; 98(2): 159-66.PubMed

230.

Barnes CP, Sell SA, Boland ED, Simpson DG, Bowlin GL: Nanofiber technology: designing the next generation of tissue engineering scaffolds. Adv Drug Deliv Rev 2007; 59(14): 1413-33.PubMedCrossRef

231.

Federle W, Barnes WJ, Baumgartner W, Drechsler P, Smith JM: Wet but not slippery: boundary friction in tree frog adhesive toe pads. J R Soc Interface 2006; 3(10): 689-97.PubMedCrossRef

232.

Majumder A, Ghatak A, Sharma A: Microfluidic adhesion induced by subsurface microstructures. Science 2007; 318(5848): 258-61.PubMedCrossRef

233.

Boesel LF, Greiner C, Arzt E, del Campo A: Gecko-inspired surfaces: a path to strong and reversible dry adhesives. Adv Mater 2010; 22(19): 2125-37.PubMedCrossRef

234.

Fernandez-Blazquez JP, Fell D, Bonaccurso E, del Campo A: Superhydrophilic and superhydrophobic nanostructured surfaces via plasma treatment. J Colloid Interface Sci 2011; 357(1): 234-8.PubMedCrossRef

235.

Cui J, Azzaroni O, Del Campo A: Polymer brushes with phototriggered and phototunable swelling and pH response. Macromol Rapid Commun 2011; 32(21): 1699-703.PubMedCrossRef

Titel: Current Strategies and Future Perspectives for Intraperitoneal Adhesion Prevention
verfasst von: Christoph Brochhausen
Volker H. Schmitt
Constanze N. E. Planck
Taufiek K. Rajab
David Hollemann
Christine Tapprich
Bernhard Krämer
Christian Wallwiener
Helmut Hierlemann
Rolf Zehbe
Heinrich Planck
C. James Kirkpatrick
Publikationsdatum: 01.06.2012
Verlag: Springer-Verlag
Erschienen in: Journal of Gastrointestinal Surgery / Ausgabe 6/2012
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-011-1819-9

Neu im Fachgebiet Chirurgie

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO₂-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Introduction

Discussion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2012

Effect of Surgical Approach on 30-Day Mortality and Morbidity After Elective Colectomy: a NSQIP Study

Risk Factors of Portal Vein Thrombosis in Crohn’s Disease Patients

Carcinosarcoma of the Gallbladder Manifesting as Cholangitis Due to Hemobilia

Selecting a Surgical Modality to Treat a Splenic Hydatid Cyst: Total Splenectomy or Spleen-Saving Surgery?

Thoracoscopic Esophagectomy and Hand-Assisted Laparoscopic Gastric Mobilization for Esophageal Cancer with Situs Inversus Totalis

Achalasia: Pneumatic Dilation or Laparoscopic Heller Myotomy?

Update Chirurgie